# PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

> **NCT04613375** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1821 (actual)

## Conditions studied

- Community Acquired Pneumonia (CAP)

## Interventions

- **DIAGNOSTIC_TEST:** Urine sample collection
- **DIAGNOSTIC_TEST:** Saliva collection

## Key facts

- **NCT ID:** NCT04613375
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-12
- **Primary completion:** 2023-10-25
- **Final completion:** 2024-03-24
- **Target enrollment:** 1821 (ACTUAL)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04613375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04613375, "PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04613375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*